levoxyl Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Levoxyl, and what generic alternatives are available?
Levoxyl is a drug marketed by King Pharms and is included in one NDA.
The generic ingredient in LEVOXYL is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levoxyl
A generic version of levoxyl was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
Summary for levoxyl
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 114 |
Clinical Trials: | 1 |
Patent Applications: | 6,897 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for levoxyl |
Drug Sales Revenues: | Drug sales revenues for levoxyl |
What excipients (inactive ingredients) are in levoxyl? | levoxyl excipients list |
DailyMed Link: | levoxyl at DailyMed |
Recent Clinical Trials for levoxyl
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | N/A |
Children's Hospital of Philadelphia | N/A |
Pharmacology for levoxyl
Drug Class | l-Thyroxine |
Anatomical Therapeutic Chemical (ATC) Classes for levoxyl
US Patents and Regulatory Information for levoxyl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-001 | May 25, 2001 | AB1,AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-007 | May 25, 2001 | AB1,AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-004 | May 25, 2001 | AB1,AB3 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-012 | May 25, 2001 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for levoxyl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-005 | May 25, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-002 | May 25, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-010 | May 25, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
King Pharms | LEVOXYL | levothyroxine sodium | TABLET;ORAL | 021301-010 | May 25, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for levoxyl
See the table below for patents covering levoxyl around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1365745 | ⤷ Try a Trial | |
Japan | 2005517720 | ⤷ Try a Trial | |
Australia | 2002362468 | ⤷ Try a Trial | |
Australia | 2002332507 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |